Clinical Study
A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms
Table 4
Multiple regression analysis of mean ureteral stent symptom score at 1st week and 3rd week in three groups.
| Variables | Group A Tadalafil | | Group B Tamsulosin | | Group C Placebo | | | | OR (CI) | value | | | OR (CI) | value |
| Urinary symptoms >20 | 24 | | 29 | 0.65 (0.30–1.42) | 0.28 | | 0 | 86.82 (5.09–991.42) | <0.0001 | Body pain >10 | 23 | | 6 | 5.95 (2.16–16.37) | 0.0006 | | 1 | 40.25 (5.15–314.32) | <0.0001 | Sexual health >5 | 22 | | 2 | 19.25 (4.21–88.03) | <0.0001 | | 1 | 35.93 (4.60–280.50) | <0.0001 | General health >3 | 31 | | 22 | 1.8 (0.86–4.13) | 0.12 | | 2 | 35.43 (7.76–161.84) | <0.0001 | Work performance >2 | 27 | | 27 | 0.96 (0.44–2.08) | 0.92 | | 13 | 3.07 (1.34–7.08) | 0.008 | Additional problems >1 | 19 | | 9 | 2.69 (1.08–6.71) | 0.03 | | 8 | 3.0227 (1.18–7.77) | 0.02 |
|
|